Literature DB >> 28884240

The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited.

Robério Amorim de Almeida Pondé1,2,3,4.   

Abstract

Viral hepatitis is a liver infection caused by one of the six hepatitis viruses: hepatitis A, B, C, D, E, and G virus (HAV to HEV and HGV). These agents differ in their biological, immunological, pathological and epidemiological characteristics. They cause infections that, when symptomatic, lead to clinical manifestations and laboratory findings that are not specific to a particular virus, often making differential diagnosis difficult, especially when no knowledge is available regarding the patient's medical history or the epidemiological background. A number of acute-phase serological markers, such as anti-HAV, anti-HBc, anti-HDV and anti-HEV IgM antibodies, are able to provide a clear indication of an infection caused by HAV, HBV, HDV or HEV. Anti-HCV antibodies and HGV/RNA are used for the diagnosis of HCV and HGV infections. The importance of each of these markers will be reviewed, and different factors that can interfere with the diagnosis of acute infections caused by these viruses will be described.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28884240     DOI: 10.1007/s00705-017-3538-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  Antibody response in COVID-19 patients with and without re-positive RT-PCR results during the convalescent phase.

Authors:  Jing Peng; Zhi-Yong Liu; Xiao-Juan Yu; Xiao-Yan Chen; Kai Zhang; Yi Liu; Ying-Ying Su; Chang-Qing Sun
Journal:  Arch Virol       Date:  2021-06-08       Impact factor: 2.685

2.  Viral hepatitis and Treponema pallidum prevalence in persons who underwent premarital blood tests in Argentina.

Authors:  Patricia Angeleri; Valeria Levite; Gabriela Vidiella; Joaquín Solari; Emma Coronel; Dan Adaszko; Ariel Adaszko; Cecilia Moyano; Diosnel Bouchet; Héctor Cuello; Viviana Molfese; Rosario Skarzauskas; Marcelo Vila; Carlos Falistocco; Maria A Pando
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

3.  Enduring Challenges despite Progress in Preventing Mother-to-Child Transmission of Hepatitis B Virus in Angola.

Authors:  Luis Baião Peliganga; Marco Aurélio Pereira Horta; Lia Laura Lewis-Ximenez
Journal:  Pathogens       Date:  2022-02-08

4.  Seroprevalence of hepatitis B and C viral infections in the premarital adult population of Al Majmaah, Saudi Arabia.

Authors:  Shabir Ahmad Mir; Bader Alshehri
Journal:  Malawi Med J       Date:  2021-09       Impact factor: 0.875

5.  Assay Sensitivity Difference Can Induce Anti-Hepatitis A Virus IgM Non-Reactive But Total (IgM and IgG) Reactive Results in Early Acute Hepatitis A.

Authors:  Soo-Kyung Kim; Kwon Yoo; Jungwon Huh
Journal:  J Korean Med Sci       Date:  2022-09-26       Impact factor: 5.354

6.  Anti-HDV seroprevalance among patients with previous HBV infection.

Authors:  Abdurrahman Sahin; Suzan Gurocak; Nurettin Tunc; Ulvi Demirel; Orhan Kursat Poyrazoglu; Handan Akbulut; Mehmet Yalniz; Zulal Asci Toraman; Ibrahim Halil Bahcecioglu
Journal:  North Clin Istanb       Date:  2018-05-21

7.  Development and Evaluation of a Molecular Hepatitis A Virus Assay for Serum and Stool Specimens.

Authors:  Robert A Kozak; Candace Rutherford; Melissa Richard-Greenblatt; N Y Elizabeth Chau; Ana Cabrera; Mia Biondi; Jamie Borlang; Jaqueline Day; Carla Osiowy; Sumathi Ramachandran; Nancy Mayer; Laurel Glaser; Marek Smieja
Journal:  Viruses       Date:  2022-01-15       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.